Clinical Genetic Diagnostics
Cystic Fibrosis, Prenatal, Infectious Disease
Key Facts
About Retrogen
Retrogen is an established, privately-held service provider in the genomics and diagnostics sector, leveraging both foundational Sanger sequencing and modern NGS platforms like Ion Torrent PGM and Oxford Nanopore. Its business model is dual-focused, serving research clients with genomic services while also operating a CLIA/CAP-accredited clinical lab for diagnostic testing, including COVID-19 and genetic disease panels. The company has built a stable revenue-generating operation by catering to diverse customer segments from academia to healthcare, though it operates in a highly competitive commoditized service market. Its strategic positioning combines technical reliability with a expansion into higher-value clinical diagnostic applications.
View full company profile